Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients With Coexistent Heart Failure and Atrial Fibrillation
Source : https://link.springer.com/article/10.1007/s12265-023-10454-x
The coexistence of heart failure (HF) and atrial fibrillation (AF) worsens the prognosis of patients. We aimed to study the inflammation, metabolism, adiposity, and fibrosis markers on epicardial and subcutaneous...
Plasma FABP4 was identified as the main heart failure (HF) predictor. Higher levels of adiposity markers are associated with atrial fibrillation (AF) or HF and higher stretch and fibrosis markers with combined AF and HF.
Cryoballoon Ablation for Atrial Fibrillation in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction: a Systematic Review and Meta-Analysis
Source : https://pubmed.ncbi.nlm.nih.gov/37877802/
The coexistence of atrial fibrillation (AF) with heart failure (HF) is prevalent, leading to severe complications.
These study results indicated a noteworthy effect of cryoablation in mitigating atrial fibrillation (AF) recurrence, alongside a success rate, denoted by freedom from AF at 1 and 2 years postprocedure.
Prognostic Impact of Abnormal Sodium Burden in Heart Failure Patients With Preserved Ejection Fraction
Source : https://pubmed.ncbi.nlm.nih.gov/37877605/
In HFpEF patients, abnormal sodium burden was an independent predictor long-term any-cause mortality and HF hospitalization.
In patients with heart failure and preserved ejection fraction, abnormal sodium burden was an independent predictor long-term any-cause mortality and HF hospitalization.
Utilization Patterns of Cardiovascular Medications in Patients With Diabetes Mellitus: a Retrospective Cross-Sectional Study, 2013-17
Source : https://pubmed.ncbi.nlm.nih.gov/37848743/
The present study reflects that medication utilization patterns were rational, according to the standard treatment guidelines. Utilization patterns of medications that are recommended for both prevention and treatment of CVD...
Researchers from the Middle East studied the utilization patterns of CVD medications in patients with T2DM for 4 years. Women had the highest rate of utilization of CVD medications across the entire study range. Utilization patterns of medications recommended for prevention and treatment of CVD in diabetes were observed to be the highest.
Relationship Between Comorbidity and Health Outcomes in Patients With Heart Failure: a Systematic Review and Meta-Analysis
Source : https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03527-x
Background The prevalence of heart failure (HF) is expected to rise due to increased survivorship and life expectancy of patients with acute heart conditions. Patients with HF and other multiple...
Comorbidities have significantly negative pooled effects on HF patient health outcomes, especially in regard to the prognostic health outcomes. Clinicians should carefully identify and manage these conditions when implementing HF interventions to improve prognostic outcomes.